BIO — Biome Grow Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Biome Grow, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.86 | -9.48 | -1.72 | -0.14 | -10.9 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.37 | 5.92 | -1.89 | -0.913 | 10.3 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.385 | 1.3 | 2.6 | -0.786 | -0.141 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.62 | -2.22 | -1.01 | -1.84 | -0.743 |
| Capital Expenditures | -3.39 | -1.75 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.023 | 0 | 1.81 | 2.16 | 0.261 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.41 | -1.75 | 1.81 | 2.16 | 0.261 |
| Financing Cash Flow Items | -0.479 | — | -0.131 | -0.069 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.82 | 4.18 | -2.29 | -0.31 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.21 | 0.205 | -1.5 | 0.014 | -0.482 |